Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...